Clinical Trials
20 trialsNCT05054725 2026-01-06
Combination Study of RMC-4630 and Sotorasib for NSCLC Subjects With KRASG12C Mutation After Failure of Prior Standard Therapies
Revolution Medicines, Inc.
Phase 2 Completed
NCT06145750 2025-11-24
FIRSTLUNG
Delfi Diagnostics Inc.
Phase NA Completed
NCT04702165 2025-07-29
Image - Navigated Resection of Lung Nodules
Navigation Sciences, Inc.
Phase 1/2 Completed
NCT03613363 2025-06-06
Engineering Evaluation of the Helix Ventilator
Philips Respironics
Phase NA Completed
NCT03037385 2025-05-31
ARROW
Hoffmann-La Roche
Phase 1/2 Completed
NCT04774952 2025-04-15
Dose Escalation of RMC-5552 Monotherapy in Relapsed/Refractory Solid Tumors
Revolution Medicines, Inc.
Phase 1 Completed
NCT06465797 2024-06-20
Observational Bronchoscopy Video Data Collection Study With Adult Patients
Ambu A/S
Completed
NCT05594485 2023-07-13
Retrospective Study of Carebot AI CXR Performance in Preclinical Practice
Carebot s.r.o.
Completed
NCT03989115 2023-06-26
Dose-Esc/Exp RMC4630 & Cobi in Relapsed/Refractory Solid Tumors & RMC4630& Osi in EGFR+ Locally Adv/Meta NSCLC
Revolution Medicines, Inc.
Phase 1/2 Completed
NCT02926768 2022-07-26
Phase I/II Study of CK-101 in NSCLC Patients and Other Advanced Solid Tumors
Checkpoint Therapeutics, Inc.
Phase 1 Completed
NCT04770675 2022-05-03
Post Market Study to Collect Data for Software Recognizing the Anatomical Structures During Bronchoscopy.
Qmed Consulting A/S
Completed
NCT02897778 2022-04-28
Cardiac Safety Study of Entinostat in Men and Women With Advanced Solid Tumors
Syndax Pharmaceuticals
Phase 1 Completed
NCT02909452 2022-01-25
Continuation Study of Entinostat in Combination With Pembrolizumab in Patients With Advanced Solid Tumors
Syndax Pharmaceuticals
Phase 1 Completed
NCT01594398 2021-11-19
ENCORE110
Syndax Pharmaceuticals
Phase 1 Completed
NCT02259582 2020-09-09
DENALI
Mereo BioPharma
Phase 2 Completed
NCT03134872 2020-06-09
A Study of SHR-1210 in Combination With Pemetrexed and Carboplatin in Subjects With Non-squamous NSCLC
Jiangsu HengRui Medicine Co., Ltd.
Phase 3 Completed
NCT01039948 2015-04-08
A Phase 1b/2 Study in Asian Subjects With Non-Small Cell Lung Cancer
AVEO Pharmaceuticals, Inc.
Phase 1/2 Completed
NCT00284141 2012-12-10
Study of AVE0005 (VEGF Trap) in Locally Advanced or Metastatic Platinum- and Erlotinib- Resistant Non-small-cell-lung Adenocarcinoma
Sanofi
Phase 2 Completed
NCT00293514 2012-05-07
TachoSil Versus Standard Surgical Treatment for Air Leakage in Pulmonary Lobectomy (TC-021-IM)
Nycomed
Phase 3 Completed
NCT00886353 2009-12-31
Safety and Tolerability Study of APN01 (Recombinant Human Angiotensin Converting Enzyme 2)
Apeiron Biologics
Phase 1 Completed